Weleda AG

Research activity is centered on functional cardiovascular disorders, with attention to symptom patterns and clinical endpoints relevant to this group of conditions. The funded trial landscape includes work on Cardiodoron® in comparison with placebo in people with cardiovascular complaints that are not defined by structural heart disease.

• Functional cardiovascular symptoms
• Cardiovascular endpoint assessment
• Symptom relief evaluation

Clinical interest extends to identifying outcomes that can capture treatment effects in patients with functional cardiac symptoms and related circulatory complaints.